Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The Rheumatoid Arthritis DMARD Intervention and Utilization Study (RADIUS 1) is designed to
systematically collect and document use patterns, effectiveness, and safety of DMARD
treatments currently used in the management of rheumatoid arthritis (RA). It is anticipated
that study data may help improve the quality of information upon which clinical decisions are
based.
Details
Lead Sponsor:
Amgen
Collaborators:
Immunex Corporation Wyeth is now a wholly owned subsidiary of Pfizer